Table Of Contents
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definitions
1.2.1 Service
1.2.2 Formulation
1.2.3 Therapeutic Area
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Information analysis
1.4.2 Market formulation & data visualization
1.4.3 Data validation & publishing
1.5 Research Scope and Assumptions
1.5.1 Commodity Flow Analysis
1.5.2 Top-down market estimation
1.5.3 Country-based segment share calculation
1.5.4 Multivariate analysis
1.5.5 DTC Genetic Testing Market: CAGR Calculation
1.6 List of Secondary Sources
1.7 Objectives
1.7.1 Objective – 1:
1.7.2 Objective – 2:
1.7.3 Objective – 3:
1.7.4 Objective – 4:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 DTC Genetic Testing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.2 Market Restraint Impact Analysis
3.3 Industry Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel Analysis
3.4 COVID-19 Impact on DTC Genetic Testing Market
3.4.1 Activities By Market Players
3.4.2 Long-Term Changes In The Market
Chapter 4 DTC Genetic Testing Market: Test Type Estimates & Trend Analysis
4.1 DTC Genetic Testing Market by Test Type: Key Takeaways
4.2 Test type Movement Analysis & Market Share, 2023 & 2030
4.3 DTC Genetic Testing Market Estimates & Forecast, By Test Type (USD Million)
4.3.1 Nutrigenomics Testing
4.3.2 Predictive Testing
4.3.3 Carrier Testing
4.3.4 Others
Chapter 5 DTC Genetic Testing Market: Technology Estimates & Trend Analysis
5.1 DTC Genetic Testing Market by Technology: Key Takeaways
5.2 Technology Movement Analysis & Market Share, 2023 & 2030
5.3 DTC Genetic Testing Market Estimates & Forecast, By Technology (USD Million)
5.3.1 Whole Genome Sequencing
5.3.2 Single Nucleotide Polymorphism Chips
5.3.3 Targetes Analysis
5.3.4 Others
Chapter 6 DTC Genetic Testing Market: Distribution Channel Estimates & Trend Analysis
6.1 DTC Genetic Testing Market by distribution channel: Key Takeaways
6.2 Distribution Channel Movement Analysis & Market Share, 2023 & 2030
6.3 DTC Genetic Testing Market Estimates & Forecast, By distribution channel (USD Million)
6.3.1 Online Platform
6.3.2 OTC
Chapter 7 DTC Genetic Testing Market: Regional Analysis
7.1 DTC Genetic Testing Market: Regional Outlook
7.2 DTC Genetic Testing Market by Region: Key Takeaways
7.3 DTC Genetic Testing Market by Region: Key Takeaway
7.4 North America
7.4.1 North America DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4.2 U.S.
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Prevalence Insights
7.4.2.4 Regulatory Framework
7.4.2.5 Reimbursement Structure
7.4.2.6 U.S. DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4.3 Canada
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 Prevalence Insights
7.4.3.4 Regulatory Framework
7.4.3.5 Reimbursement Structure
7.4.3.6 Canada DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5 Europe
7.5.1 Europe DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.2 UK
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Prevalence Insights
7.5.2.4 Regulatory Framework
7.5.2.5 Reimbursement Structure
7.5.2.6 UK DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.3 Germany
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Prevalence Insights
7.5.3.4 Regulatory Framework
7.5.3.5 Reimbursement Structure
7.5.3.6 Germany DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.4 France
7.5.4.1 Key Country Dynamics
7.5.4.2 Competitive Scenario
7.5.4.3 Prevalence Insights
7.5.4.4 Regulatory Framework
7.5.4.5 Reimbursement Structure
7.5.4.6 France DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.5 Italy
7.5.5.1 Key Country Dynamics
7.5.5.2 Competitive Scenario
7.5.5.3 Prevalence Insights
7.5.5.4 Regulatory Framework
7.5.5.5 Reimbursement Structure
7.5.5.6 Italy DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.6 Spain
7.5.6.1 Key Country Dynamics
7.5.6.2 Competitive Scenario
7.5.6.3 Prevalence Insights
7.5.6.4 Regulatory Framework
7.5.6.5 Reimbursement Structure
7.5.6.6 Spain DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.7 Denmark
7.5.7.1 Key Country Dynamics
7.5.7.2 Competitive Scenario
7.5.7.3 Prevalence Insights
7.5.7.4 Regulatory Framework
7.5.7.5 Reimbursement Structure
7.5.7.6 Denmark DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.8 Sweden
7.5.8.1 Key Country Dynamics
7.5.8.2 Competitive Scenario
7.5.8.3 Prevalence Insights
7.5.8.4 Regulatory Framework
7.5.8.5 Reimbursement Structure
7.5.8.6 Sweden DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5.9 Norway
7.5.9.1 Key Country Dynamics
7.5.9.2 Competitive Scenario
7.5.9.3 Prevalence Insights
7.5.9.4 Regulatory Framework
7.5.9.5 Reimbursement Structure
7.5.9.6 Norway DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.6 Asia Pacific
7.6.1 Asia Pacific DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.6.2 China
7.6.2.1 Key Country Dynamics
7.6.2.2 Competitive Scenario
7.6.2.3 Prevalence Insights
7.6.2.4 Regulatory Framework
7.6.2.5 Reimbursement Structure
7.6.2.6 China DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.6.3 India
7.6.3.1 Key Country Dynamics
7.6.3.2 Competitive Scenario
7.6.3.3 Prevalence Insights
7.6.3.4 Regulatory Framework
7.6.3.5 Reimbursement Structure
7.6.3.6 India DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.6.4 Japan
7.6.4.1 Key Country Dynamics
7.6.4.2 Competitive Scenario
7.6.4.3 Prevalence Insights
7.6.4.4 Regulatory Framework
7.6.4.5 Reimbursement Structure
7.6.4.6 Japan DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.6.5 Australia
7.6.5.1 Key Country Dynamics
7.6.5.2 Competitive Scenario
7.6.5.3 Prevalence Insights
7.6.5.4 Regulatory Framework
7.6.5.5 Reimbursement Structure
7.6.5.6 Australia DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.6.6 Thailand
7.6.6.1 Key Country Dynamics
7.6.6.2 Competitive Scenario
7.6.6.3 Prevalence Insights
7.6.6.4 Regulatory Framework
7.6.6.5 Reimbursement Structure
7.6.6.6 Thailand DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.6.7 South Korea
7.6.7.1 Key Country Dynamics
7.6.7.2 Competitive Scenario
7.6.7.3 Prevalence Insights
7.6.7.4 Regulatory Framework
7.6.7.5 Reimbursement Structure
7.6.7.6 South Korea DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.7 Latin America
7.7.1 Latin America DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.7.2 Brazil
7.7.2.1 Key Country Dynamics
7.7.2.2 Competitive Scenario
7.7.2.3 Prevalence Insights
7.7.2.4 Regulatory Framework
7.7.2.5 Reimbursement Structure
7.7.2.6 Brazil DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.7.3 Mexico
7.7.3.1 Key Country Dynamics
7.7.3.2 Competitive Scenario
7.7.3.3 Prevalence Insights
7.7.3.4 Regulatory Framework
7.7.3.5 Reimbursement Structure
7.7.3.6 Mexico DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.7.4 Argentina
7.7.4.1 Key Country Dynamics
7.7.4.2 Competitive Scenario
7.7.4.3 Prevalence Insights
7.7.4.4 Regulatory Framework
7.7.4.5 Reimbursement Structure
7.7.4.6 Argentina DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.8 Middle East & Africa
7.8.1 Middle East & Africa DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.8.2 South Africa
7.8.2.1 Key Country Dynamics
7.8.2.2 Competitive Scenario
7.8.2.3 Prevalence Insights
7.8.2.4 Regulatory Framework
7.8.2.5 Reimbursement Structure
7.8.2.6 South Africa DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.8.3 Saudi Arabia
7.8.3.1 Key Country Dynamics
7.8.3.2 Competitive Scenario
7.8.3.3 Prevalence Insights
7.8.3.4 Regulatory Framework
7.8.3.5 Reimbursement Structure
7.8.3.6 Saudi Arabia DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.8.4 UAE
7.8.4.1 Key Country Dynamics
7.8.4.2 Competitive Scenario
7.8.4.3 Prevalence Insights
7.8.4.4 Regulatory Framework
7.8.4.5 Reimbursement Structure
7.8.4.6 UAE DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.8.5 Kuwait
7.8.5.1 Key Country Dynamics
7.8.5.2 Competitive Scenario
7.8.5.3 Prevalence Insights
7.8.5.4 Regulatory Framework
7.8.5.5 Reimbursement Structure
7.8.5.6 Kuwait DTC Genetic Testing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Ansoff matrix
8.1.2 Heat map analysis
8.1.3 Major Deals and Strategic Alliances Analysis
8.1.3.1 Joint Ventures
8.1.3.2 Licensing Agreements
8.1.3.3 Product Launches
8.1.3.4 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.5 Private Companies
8.5.1 List of key emerging companies
8.6 Company Profiles
8.6.1 23andMe
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic Initiatives
8.6.2 Illumina, Inc.
8.6.2.1 Company overview
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic Initiatives
8.6.3 Family Tree DNA
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 Ancestry
8.6.4.1 Company overview
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic Initiatives
8.6.5 Myriad Genetics, Inc.
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 Genesis HealthCare
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic Initiatives
8.6.7 EasyDNA
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 Veritas
8.6.8.1 Company overview
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 Full Genomes Corporation, Inc
8.6.9.1 Company overview
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.9.4 Strategic initiatives
8.6.10 Living DNA Ltd.
8.6.10.1 Company overview
8.6.10.2 Financial performance
8.6.10.3 Product benchmarking
8.6.10.4 Strategic initiatives
8.6.11 Color Health, Inc.
8.6.11.1 Company overview
8.6.11.2 Financial performance
8.6.11.3 Product benchmarking
8.6.11.4 Strategic initiatives
|
